Transforming Long-term Post-Acute Care for the Aging Population through Home Infusion Therapy in China: Assurance for Quality and Safety of Care Delivery (Part 2)

Wei Zuo^1,2Zi Yin Zhou³Kayla Huynh⁴Dylan H. Do⁵Dan Mei²Tu Tran⁶JIanchun Yu²Hong Yang²Wei Chen²Bin Zhao²Vivian W Y Lee⁷Fan Zhang²Shaohong Wang²Shan Li²Austin-Phong Nguyen⁸Connie Vo⁹Huijie Shi¹⁰Jennifer Le^1,8*

• ¹Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, United States
• ²Peking Union Medical College Hospital, Beijing, China
• ³University of California San Diego, La Jolla, United States
• ⁴University of California Davis, Davis, United States
• ⁵Dartmouth College, Hanover, United States
• ⁶Huntington Hospital, Huntington, United States
• ⁷The Chinese University of Hong Kong, Hong Kong, Hong Kong, SAR China
• ⁸Tylan Health, El Monte, United States
• ⁹Comfort Home Health & Hospice Care Inc, Long Beach, United States
• ¹⁰Shenzhen People's Hospital, Shenzhen, China

Background: China’s healthcare system may benefit from the integration of home infusion therapy (HIT) combined with home health services (HHS) to address the urgent need for a sustainable long-term, post-acute care model for the aging population and those with chronic complex diseases. In this Part 2, we presented the current landscape of home- and community-based care models in China and formulated recommendations for successful implementation of HIT and HHS. Methods: We conducted a literature search up to October 2025 using MEDLINE, EMBASE, PubMed, Web of Science, and China National Knowledge Infrastructure. Results: To address the urgent need to support aging at home, China has initiated home- and community-based services nationwide. Despite these services, including a pilot of hospital-at-home, utilization remains low due to limited facilities, suboptimal service quality, and inadequate promotion. Notably, HIT and HHS that provide outpatient parenteral antibiotic therapy and total parenteral nutrition at home, and chemotherapy at infusion centers have not been adopted in China; yet this value-based modality has existed in western countries (including the United States, the United Kingdom, Australia, Canada, France, among others) for decades to provide patient-centric care that is safe and cost-effective. Implementing HIT requires a robust accreditation system, sterile compounding standards, technological integration, and professional training to ensure patient safety and quality of care. Conclusion: The shift of care from hospitals to homes through HIT supported by HHS holds great potential to alleviate healthcare costs, reduce hospital burden, and enhance patient comfort and dignity in China.